TG THERAPEUTICS, INC.: 10-Q filed 2015-11-09
What TG THERAPEUTICS, INC. reported in its quarterly report filed 2015-11-09 (fiscal Q3 2015): 22 published measures, 60 facts as tagged in accession 0001144204-15-063716.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-11-09
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001144204-15-063716 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TG THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 127,407,138 | USD | |
| At 2014-12-31 | 86,746,890 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 11,095,326 | USD | |
| At 2014-12-31 | 6,645,006 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 65,461,940 | USD | |
| At 2014-12-31 | 55,713,784 | USD | |
| At 2014-09-30 | 53,225,799 | USD | |
| At 2013-12-31 | 40,485,466 | USD |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 59,194 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 4,498 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | -140,522,114 | USD | |
| At 2014-12-31 | -95,185,280 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 69,225 | USD | |
| At 2014-12-31 | 20,357 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 12,840,048 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 16,066,856 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -13,825,584 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -45,540,015 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -17,439,346 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -36,999,968 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 104,730,487 | USD | |
| At 2014-12-31 | 85,215,029 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 246,527 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 730,710 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 234,787 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 695,914 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 9,685,802 | USD | |
| At 2014-12-31 | 5,121,196 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 799,391 | USD | |
| At 2014-12-31 | 799,391 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 13,863,680 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 45,654,301 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 17,477,442 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 37,114,254 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 11,574,002 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 32,453,001 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 13,691,573 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 24,949,573 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 52,516,908 | shares | |
| At 2014-12-31 | 44,932,939 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 257,015,699 | USD | |
| At 2014-12-31 | 175,476,521 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 116,311,812 | USD | |
| At 2014-12-31 | 80,101,884 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 141,717 | USD | |
| At 2014-12-31 | 137,101 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -13,655,916 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -45,336,834 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -17,451,169 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -36,984,848 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 2,289,678 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 13,201,300 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 3,785,869 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 12,164,681 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 10,326 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 2,454 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 169,668 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 203,181 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -11,823 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 15,120 | USD | 273 |
Inspect the source
- Entity
- TG THERAPEUTICS, INC. / CIK 0001001316
- Captured
- 2026-09-20T05:11:16.212Z
- SEC response SHA-256
153d276440c1903144d2ca193676af4b7014428a3e4b5524efe33528427880b3
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001001316.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))